Scope of Ferrum Phosphoricum 6X with or without iron supplements in treating Anaemia in adolescent girls

Treatment efficacy of Ferrum Phosphoricum 6X administered as monotherapy or co-intervention with iron supplements for mild to moderate anaemia in adolescent girls: a single-blind randomized control trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102684

Enrollment

Registered

2026-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: HOMOEOPATHIC MEDICINE: Group 1 participants will be prescribed Ferrum Phos 6X diskettes as 2 tablets 3 times a day and Group 2 will be prescribed Ferrum Phos 6x diskettes 2 tablets 3

Eligibility

Inclusion criteria

Inclusion criteria: 1)Adolescent girls diagnosed with mild to moderate Iron deficiency Anaemia. Haemoglobin level from 8g per dl to 11.99g per dl according to UNICEF 2)Age group 10 to 16 years 3)Case in which parents will give assent for their children

Exclusion criteria

Exclusion criteria: 1)Cases with active history of blood loss like menometrorrhagia, bleeding per rectum 2)Cases with recent History Of of malaria, dengue in past 3 months 3)Pregnant adolescent girls 4)Known case of thalassemia, sickle cell anemia, Chronic illness or infection TB, HIV, renal disease

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Ferrum Phosphoricum 6X, administered either as monotherapy or as a co-intervention with iron supplements, compared to placebo, in improving clinical symptoms and hematological parameters (Hemoglobin levels, blood indices, and peripheral smear for RBC morphology) over a period of 6 months in adolescent girls with mild to moderate anemia.Timepoint: 0 MONTHS, 3 MONTHS, 6 MONTHS	—

Measure

Time frame

To evaluate the efficacy of Ferrum Phosphoricum 6X, administered either as monotherapy or as a co-intervention with iron supplements, compared to placebo, in improving clinical symptoms and hematological parameters (Hemoglobin levels, blood indices, and peripheral smear for RBC morphology) over a period of 6 months in adolescent girls with mild to moderate anemia.Timepoint: 0 MONTHS, 3 MONTHS, 6 MONTHS

—

Secondary

Measure	Time frame
To determine the optimum duration of treatment with Ferrum Phosphoricum 6X required to achieve a significant increase in hemoglobin levels in adolescent girls with mild to moderate anemia over a period of 6 monthsTimepoint: 0 MONTHS, 3 MONTHS, 6 MONTHS	—

Countries

India

Contacts

Public ContactDr Omkar Anavkar

Dr M L Dhawale Memorial Homoeopathic Institute

omkaranavkar@gmail.com7039499102

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026